Anavex Life Sciences Corp (AVXL)

[nidan7500]

If we are correct, they are managing a fine line. It looks like he has set a plan that includes collaboration w/a very few selected-trusted bodies, some 3rd party (RS-Lund-others). Demonstration of clinical concepts using AI and the validation of the homeostasis thesis could occur in one sequence of selected planned and sequenced trials. It is obvious but worth noting that RS-PD results may present dramatic changes in patients in minimal et.

He does not need or want a cast of thousands around him in order to succeed in the next stage of development/proof. In fact a bigger cast adds weight but not lift. The dark side of that thinking is it takes longer to get things done w/thin resources, hence the need for silence I guess.

We will probably know before the fall time. Semper fi.